Fla. Admin. Code R. 63N-1.0051
(1) Screening in Juvenile Assessment Centers (JAC) or Juvenile Probation Officer (JPO) Unit.
(a) Mental Health and Substance Abuse Screening conducted upon a youth’s initial intake at a JAC or JPO Unit shall include the following:
1. Administration of the Massachusetts Youth Screening Instrument, Second Version (MAYSI-2).
2. Administration of the Suicide Risk Screening Instrument (SRSI) Form (MHSA 002, October 2014) which is incorporated by reference and is available at HYPERLINK "http://www.flrules.org/Gateway/reference.asp?No=Ref-05366" http://www.flrules.org/Gateway/reference.asp?No=Ref-05366, or may be obtained by contacting: DJJ, Office of Health Services, 2737 Centerview Drive, Tallahassee, FL 32399.
3. Completion of the PACT and PACT Mental Health and Substance Abuse Screening Report and Referral Form as set forth in Rule 63D-9.004, F.A.C.
(2) Screening in Detention Centers.
(a) Mental Health and Substance Abuse Screening conducted upon a youth’s admission to a Detention Center shall include the following:
1. Review of the youth’s MAYSI-2, PACT Mental Health and Substance Abuse Screening Report and Referral Form and the SRSI sections administered by the JPO or JAC intake screener prior to the youth’s admission to the Detention Center; and,
2. Administration of the Suicide Risk Screening Instrument (SRSI) Form (MHSA 002).
(3) Screening in Residential Commitment Programs.
(b) Mental Health and Substance Abuse Screening shall include a review of each youth’s commitment packet information, reports and records and administration of either the Massachusetts Youth Screening Instrument, Second Version (MAYSI-2) or Clinical Mental Health and Substance Abuse Screening.
1. Residential program intake staff administering Mental Health and Substance Abuse Screening must review each youth’s commitment packet information, reports and records for existing documentation of mental health or substance abuse problems, needs or risk factors.
2. The residential program intake staff must note any existing documentation of mental health or substance abuse problems, needs or risk factors and report the documentation to appropriate Mental Health Clinical Staff.
(c) Either the MAYSI-2 or Clinical Mental Health and Clinical Substance Abuse Screening must be administered upon each youth’s admission to a residential commitment program.
1. If the MAYSI-2 is to be administered at intake/admission to a residential commitment program, the procedures specified in Rule 63N-1.0053, F.A.C., must be followed:
2. If Clinical Mental Health and Clinical Substance Abuse Screening are to be administered at intake/admission to a residential commitment program as an alternative to the MAYSI-2, the procedures specified in paragraphs (d) and (e), below, must be followed.
(d) Clinical Mental Health Screening – General Requirements:
1. Documentation of Clinical Mental Health Screening must be provided by the Licensed Mental Health Professional and clearly identified as “Clinical Mental Health/Substance Abuse Screening.”
2. Clinical Mental Health Screening documentation must provide details of the information obtained by the screening such as youth statements, behavioral observations, collateral information. The specific information supporting the Clinical Mental Health Screening findings and recommendations must be documented on the screening instrument.
3. The Clinical Mental Health Screening document must be signed and dated by the Licensed Mental Health Professional conducting the screening.
(e) Clinical Substance Abuse Screening – General Requirements.
1. Documentation of Clinical Substance Abuse Screening must be provided by the Licensed Qualified Professional and clearly identified as “Clinical Substance Abuse Screening.”
2. Clinical Substance Abuse Screening documentation must provide details of the information obtained by the screening such as youth statements, behavioral observations, collateral information. The specific information supporting the Clinical Substance Abuse Screening findings and recommendations must be documented on the screening instrument.
3. The Clinical Substance Abuse Screening document must be signed and dated by the Licensed Qualified Professional conducting the screening.
(4) Admission Screening in Day Treatment Programs.
Mental Health and Substance Abuse Screening conducted upon a youth’s admission to a day treatment program shall include a review of each youth’s referral information and administration of the Massachusetts Youth Screening Instrument, Second Version (MAYSI-2).
Rulemaking Authority 985.64(2) FS. Law Implemented 985.601(3)(a), 985.14(3)(a), 985.145(1), 985.18, 985.48(4), 985.64(2) FS. History–New 3-16-14, Amended 7-9-15.